All news

Pic:getty/gajus

Sanofi to acquire Kymab for up to $1.45bn

By Rachel Arthur

Sanofi will acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies. The acquisition will give it global rights to KY1005, which has the potential to treat a range of immune-mediated diseases and inflammatory...

pic:getty/monticello

UK gives Moderna's COVID-19 vaccine the green light

By Rachel Arthur

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Moderna's COVID-19 vaccine for people aged 18+ in the UK: marking the fifth jurisdiction to give the vaccine the green light.

The US will administer Pfizer doses 21 days apart; the UK within 12 weeks, Denmark within six weeks. Pic: getty/earmanver

WHO weighs in on COVID-19 vaccine second dose delay

By Rachel Arthur

The World Health Organization’s vaccine advisory group recommends the two doses of the Pfizer/BioNTech vaccine should be delivered 21 to 28 days apart: although it adds that the maximum time period between doses could be up to six weeks in some situations.

Follow us

Products

View more

Webinars